Husam Balkhy, M.D. To Present Clinical Study Results Of Cardica’s C-Port Distal Anastomosis System At The Annual Meeting Of American Association For Thoracic Surgery
REDWOOD CITY, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- Cardica, Inc. (Nasdaq:CRDC) today announced that the results of a clinical study of the C-Port® Distal Anastomosis System will be presented at the Annual Meeting of the American Association for Thoracic Surgery (AATS) in Baltimore, Maryland by Husam Balkhy, M.D., associate professor of Surgery and director of Robotic and Minimally Invasive Cardiac Surgery at The University of Chicago’s Medicine & Biological Sciences Division. Dr. Balkhy’s presentation is scheduled to take place on May 17, 2016 at 7 a.m. ET.
The MAGIC (Multicenter Assessment of Grafts in Coronaries) Study, a long-term post-market evaluation of the C-Port device, examined acute-to-mid-term and long-term vein graft occlusion rates for coronary revascularization using the C-Port compared to hand-sewn anastomoses. Patients receiving at least one C-Port anastomosis during coronary artery bypass grafting (CABG) surgery were enrolled at eight sites in the United States.
About the C-Port® Distal Anastomosis Systems (C-Port systems)
The C-Port systems – the C-Port xA system and the Flex-A® system – can be used on- or off-pump and create compliant anastomoses that expand and contract with blood flow. With miniature stainless steel staples to secure the bypass graft to the coronary artery, C-Port reduces time required for anastomosis. The C-Port systems work on coronary arteries as small as 1.25 millimeters in internal diameter and work with grafts of various diameters and wall thicknesses less than 1.4 millimeters. The Flex-A system allows surgeons to position the device to create a secure connection even in the most difficult to reach areas of the heart.
About Cardica
Cardica designs and manufactures proprietary stapling and automated anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 56,500 units throughout the world. In addition, Cardica’s MicroCutter XCHANGE® 30, the world’s smallest-profile articulating stapler, is manufactured and cleared for use in the U.S. for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine and the transection of the appendix.
Contact: Investors: Bob Newell Vice President, Finance and Chief Financial Officer (650) 331-7133 investors@cardica.com Media: Jessica Volchok (310) 849-7985 jessica@nicoleosmer.com